sábado, 20 de febrero de 2010
Access to essential medicines: A very good news!
An Indian court has stopped the international pharmaceutical company Bayer’s latest attempt to introduce new measures to prevent generic competition in India. By ruling against Bayer on 9 February 2010, the Delhi High Court has refused to undermine measures in India’s patent laws that help ensure access to more affordable essential medicines for patients in need.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario